###begin article-title 0
###xml 58 63 <span type="species:ncbi:9606">human</span>
The signature of long-standing balancing selection at the human defensin beta-1 promoter
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 61 66 <span type="species:ncbi:9606">human</span>
Analysis of the human beta defensin 1 promoter region in six human populations reveals a signature of balancing selection.
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1</italic>
###xml 409 417 409 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 401 404 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Defensins, small endogenous peptides with antimicrobial activity, are pivotal components of the innate immune response. A large cluster of defensin genes is located on human chromosome 8p; among them the beta defensin 1 (DEFB1) promoterhas been extensively studied since discovery that specific polymorphisms and haplotypes associate with asthma and atopy, susceptibility to severe sepsis, as well as HIV and Candida infection predisposition.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 105 110 <span type="species:ncbi:9606">human</span>
###xml 807 812 <span type="species:ncbi:9606">human</span>
###xml 817 827 <span type="species:ncbi:9598">chimpanzee</span>
Here, we characterize the sequence variation and haplotype structure of the DEFB1 promoter region in six human populations. In all of them, we observed high levels of nucleotide variation, an excess of intermediate-frequency alleles, reduced population differentiation and a genealogy with common haplotypes separated by deep branches. Indeed, a significant departure from the expectation of evolutionary neutrality was observed in all populations and the possibility that this is due to demographic history alone was ruled out. Also, we verified that the selection signature is restricted to the promoter region and not due to a linked balanced polymorphism. A phylogeny-based estimation indicated that the two major haplotype clades separated around 4.5 million years ago, approximately the time when the human and chimpanzee lineages split.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 221 227 221 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
Altogether, these features represent strong molecular signatures of long-term balancing selection, a process that is thought to be extremely rare outside major histocompatibility complex genes. Our data indicate that the DEFB1 promoter region carries functional variants and support previous hypotheses whereby alleles predisposing to atopic disorders are widespread in modern societies because they conferred resistance to pathogens in ancient settings.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 377 378 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
Defensins comprise a large family of small endogenous peptides with antimicrobial activity against a wide range of microorganisms [1,2]. Although initially regarded as pivotal components of the innate immune system, recent evidence has indicated that defensins also play roles in the recruitment of adaptive immune cells [3] and in promoting antigen-specific immune responses [4].
###end p 10
###begin p 11
###xml 313 314 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 3 9 <span type="species:ncbi:9606">humans</span>
In humans two defensin subfamilies have been described (alpha and beta), the structural difference residing in the linear spacing and pairing of their six conserved cysteine residues. While alpha-defensins are expressed by neutrophils and intestinal Paneth cells, beta-defensins are mainly produced by epithelia [5].
###end p 11
###begin p 12
###xml 200 201 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 446 447 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 792 796 782 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis </italic>
###xml 832 837 822 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCR5 </italic>
###xml 838 839 828 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 842 848 832 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-G </italic>
###xml 849 850 839 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 853 862 843 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DQA1 </italic>
###xml 863 865 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 871 885 861 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DPA1/DPB1 </italic>
###xml 886 888 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 99 104 <span type="species:ncbi:9606">human</span>
In mammals, defensins represent large multigene families and a major defensin cluster localizes to human chromosome 8p22-23, where several alpha- and beta-defensin genes are located. Recent evidence [6] has indicated that beta-defensin genes on chromosome 8p originated by successive rounds of duplication followed by a complex evolutionary history involving both negative and positive selection with variable pressures among mammalian lineages [7]. Given the relevance of defensins in antimicrobial response and the conundrum whereby increased protein sequence diversity in the immune system enhances the spectrum of pathogen recognition, defensin coding exons have attracted much more interest in evolutionary studies compared to noncoding sequences. Yet, growing evidence suggests that 5' cis regulatory regions of genes such as CCR5 [8], HLA-G [9], HLA-DQA1 [10] and HLA-DPA1/DPB1 [11] have been subjected to balancing selection during recent primate history.
###end p 12
###begin p 13
###xml 44 50 41 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 198 200 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 236 238 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 257 259 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 260 262 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 268 276 265 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
###xml 277 279 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 334 336 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 379 385 376 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 472 478 469 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 606 612 603 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 252 255 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Among defensins, the human beta-defensin 1 (DEFB1 [OMIM *602056]) promoter has been extensively studied since specific polymorphisms and haplotypes of it have been associated with asthma and atopy [12], susceptibility to severe sepsis [13], as well as HIV [14,15] and Candida [16] infection predisposition. Moreover, recent evidence [17] has indicated that reduced expression of DEFB1 is found in a high percentage of renal and prostate cancers, therefore suggesting that DEFB1 acts as a tumor suppressor gene. These findings, together with the demonstrated functional significance of polymorphisms within DEFB1 5' regulatory sequence, indicate that this region might represent a target of natural selection.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
###xml 28 34 28 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
Nucleotide diversity at the DEFB1 promoter region
###end title 15
###begin p 16
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 677 683 677 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 1023 1028 1023 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1</italic>
###xml 1327 1333 1327 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 1373 1374 1373 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1403 1405 1399 1401 <sub xmlns:xlink="http://www.w3.org/1999/xlink">W </sub>
###xml 1406 1408 1402 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1418 1420 1413 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1448 1454 1443 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
We sequenced the 1,400 bp region immediately upstream of the DEFB1 translation start site (Figure 1) in 83 individuals with different ethnic origins (Yoruba from Nigeria [18] (YRI), Asians (AS), South American Indians (SAI), Australian Aborigines (AUA)); additional data derived from full gene resequencing of 47 subjects (24 African Americans (AA) and 23 European Americans (EA)) were retrieved from the Innate Immunity PGA (IIPGA) web site [19]. A total of 27 single nucleotide polymorphism (SNPs) were identified and haplotypes (Additional data file 1) were inferred using PHASE [20,21]. The analyzed region encompasses all polymorphic variants previously shown to modulate DEFB1 expression levels. As a control for the AA and EA populations, data for 20 promoter regions were retrieved for 20 genes in the IIPGA. In particular, the 2 kb upstream of the translation initiation site of other innate immunity genes genotyped for AA and EA were retrieved only if the initial ATG was located in the first exon (as it is for DEFB1) and if it could be unequivocally identified. Also, promoter regions were discarded if located in recombination hotspots or in resequencing gaps. A total of 20 promoter regions finally constituted the control dataset. Data concerning the number of segregating sites and nucleotide diversity at the DEFB1 promoter region are summarized in Table 1 and indicate that both thetaW [22] and pi [23] are definitely higher for DEFB1 compared to maximum values calculated for IIPGA gene promoters.
###end p 16
###begin p 17
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
Summary statistics of the DEFB1 promoter region
###end p 17
###begin p 18
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 89 90 89 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 178 179 178 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e</sup>
###xml 179 180 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 219 220 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f</sup>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 260 261 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g</sup>
###xml 261 262 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
aSample size. bNumber of segregating sites. cMaximum values for 20 IIPGA gene promoters. dPercentile rank relative to the distribution of 5 kb regions deriving from NIEHS genes. ep-value (standard neutral model) <0.01. fp-value (standard neutral model) <0.05. gp-values obtained by applying a calibrated population genetics model, as described in the text. NA, not available.
###end p 18
###begin p 19
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 55 61 55 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a-c) </bold>
###xml 98 100 93 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink">W </sub>
###xml 201 205 196 200 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 244 248 239 243 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e) </bold>
###xml 311 313 306 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ST</sub>
###xml 382 388 377 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 171 176 <span type="species:ncbi:9606">human</span>
Sliding window analysis along the DEFB1 gene sequence. (a-c) Analysis of pi (solid line) and thetaW (hatched line) is shown for AA (a, red) and EA (b, blue) together with human-macaque divergence (c). (d) Tajima's D for AA (red) and EA (blue). (e) Population differentiation between AA and EA as quantified by FST. In all cases, windows of 500 bp with a step of 2 bp were used. The DEFB1 gene structure is also shown and the shaded box denotes the region we analyzed.
###end p 19
###begin p 20
###xml 57 63 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
We excluded that the high degree of polymorphisms at the DEFB1 promoter is due to non-allelic gene conversion with other paralogous defensin genes on chromosome 8 by applying Sawyer's gene conversion algorithm [24].
###end p 20
###begin title 21
Neutrality tests
###end title 21
###begin p 22
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 343 358 343 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rhesus macaque </italic>
###xml 598 604 598 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 928 929 928 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 960 962 960 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1028 1030 1028 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1077 1083 1077 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 1184 1190 1184 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 1273 1275 1273 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 343 357 <span type="species:ncbi:9544">Rhesus macaque</span>
###xml 385 395 <span type="species:ncbi:9598">chimpanzee</span>
Under neutral evolution, the amount of within-species diversity is predicted to correlate with levels of between-species divergence, since both depend on the neutral mutation rate [25]. The HKA test [26] is commonly used to verify whether this expectation is verified. We performed both pairwise and maximum-likelihood (MLHKA) [27] tests with Rhesus macaque as an outgroup (instead of chimpanzee) so that greater divergence time results in more fixed differences and improves power to detect selection. For pairwise HKA tests we compared polymorphism and divergence level at the promoter region of DEFB1 with the 20 IIPGA genes; we consider these comparisons to be well-suited since lower sequence conservation and faster evolutionary rates are though to be a widespread feature of immune response genes [28,29]. Since IIPGA data refer to AA and EA, only these populations were used in the comparison; pairwise HKA tests (Table 2) yielded significant results (p < 0.05) in 11 out of 20 cases (with 5 additional tests yielding a p < 0.10), suggesting increased diversity at the DEFB1 promoter compared to most loci. For further confirmation, we performed a MLHKA test by comparing the DEFB1 5' region to all 20 promoter regions: a significant result was obtained (k = 3.31, p = 0.0018).
###end p 22
###begin p 23
Pairwise HKA tests
###end p 23
###begin p 24
###xml 72 74 68 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink">W </sub>
###xml 186 191 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1</italic>
###xml 226 227 216 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink">W</sub>
###xml 336 338 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 368 370 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 399 401 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 461 463 447 449 <sub xmlns:xlink="http://www.w3.org/1999/xlink">W </sub>
###xml 539 540 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 580 586 565 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
Another expectation for neutrally evolving genes is that values of thetaW and pi are roughly equal; this is the case for the maximum values of innate immunity gene promoters but not for DEFB1, which shows greater pi than thetaW, a finding consistent with an excess of intermediate frequency variants as a result of balancing selection [30]. The statistics Tajima's D [31] and Fu and Li's D* and F* [32] are commonly used to evaluate the difference between thetaW and pi and, therefore, to test departure from neutrality. As shown in Table 1, significantly positive values for the DEFB1 promoter of one or more statistics were obtained for all analyzed populations.
###end p 24
###begin p 25
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 895 897 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1065 1066 1065 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1156 1162 1156 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 1457 1459 1457 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1867 1873 1867 1873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 2016 2022 2016 2022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 2191 2193 2191 2193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 502 507 <span type="species:ncbi:9606">human</span>
It should be noted that population history, in addition to selective processes, is known [31] to affect frequency spectra and, therefore, all related statistics such as Tajima's D and Fu and Li's D* and F*. In particular, positive values of the statistics are expected under a scenario of population contraction, while negative values are consistent with an increase in population size [31,33]. We performed all tests under the standard assumption of constant population size, which is unrealistic for human populations. Still, this approach is conservative when applied to African populations since they are thought to have undergone moderate but uninterrupted population expansion [34]; in the case of non-African populations the effects of demography are more difficult to disentangle from balancing selection signatures since bottlenecks possibly occurred following migration out of Africa [34]. One possibility to circumvent this problem is to exploit the fact that selection acts on a single locus while demography affects the whole genome. As shown in Table 1, Tajima's D, as well as Fu and Li's F* and D*, displays far higher values in the case of DEFB1 compared to the maximum values of innate immunity gene promoters in EA. In order to obtain a more extensive comparison, by including YRI and subjects of Asiatic ancestry we retrieved information concerning 231 genes resequenced in AA, EA, AS and YRI from the NIEHS SNPs Program (NIEHS panel 2) [35]. In particular, for each gene a 5 kb region was randomly selected; the only requirement was that it did not contain any long (>500 bp) resequencing gaps, and if the gene did not fulfill this requirement it was discarded, as were 5 kb regions displaying less than six SNPs. The number of analyzed regions for AA, YRI, EA and AS were 209, 203, 177 and 172, respectively. We calculated the percentile rank of DEFB1 values in the distributions of Tajima's D and Fu and Li's F* and D* for this set of loci. In analogy to the results obtained above, values for DEFB1 ranked above the 95th percentile in all populations (except for Tajima's D in YRI, which ranked 93rd). It is worth mentioning that, as already noticed by other authors [36], resequenced genes in SNP discovery programs probably represent a sample biased toward non-neutrally evolving loci (in the case of the NIEHS SNPs Program, genes are selected on the basis of their having a role in organism-environment interactions), making comparison with their distribution a conservative test.
###end p 25
###begin p 26
###xml 199 204 199 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cosi </italic>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 368 373 368 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cosi </italic>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 476 477 476 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 647 653 647 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
A second possibility to disentangle the effect of demographic history from selection is to apply calibrated population genetics models. In particular, one such model that has been proposed recently, cosi [37], is based on the ability to generate realistic data rather than relying on inference about population histories. We performed coalescent simulations using the cosi package [37] and its best-fit population parameters for YRI, AA, EA and AS. Data are reported in Table 1 and indicate that for Tajima's D, as well as for Fu and Li's D* and F*, application of a calibrated model allows rejection of neutrality for the four populations at the DEFB1 promoter region.
###end p 26
###begin p 27
###xml 51 54 51 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ST </sub>
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 147 150 147 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ST </sub>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 250 253 250 253 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ST </sub>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 374 376 374 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
Population genetic differentiation, quantified by FST [38], can also be used to detect the signature of balancing selection. In particular, lower FST values are expected at loci under balancing selection compared to neutrally evolving ones [39,40]. FST among AA, EA and AS was 0.0057, much lower than the genome average of 0.123 [40] and not significantly different from 0 (p = 0.25).
###end p 27
###begin p 28
###xml 51 57 51 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 333 336 333 336 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ST </sub>
###xml 389 390 389 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 451 456 451 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1</italic>
###xml 638 640 637 639 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ST</sub>
###xml 269 274 <span type="species:ncbi:9606">human</span>
We next wished to verify that the evolution of the DEFB1 promoter is not influenced by the presence of a linked balanced polymorphism within, for example, the gene coding region. We exploited the availability of full resequencing data for the whole gene and calculated human-macaque divergence, nucleotide diversity, Tajima's D and FST in sliding windows for AA and EA. As shown in Figure 1, while inter-specific divergence is quite homogeneous along DEFB1, a peak in nucleotide diversity (expecially pi) is observed at the promoter; consistently, in both AA and EA, the same region displays the maximum Tajima's D value and the minimum FST, with no other region showing evidence suggestive of balancing selection.
###end p 28
###begin p 29
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1</italic>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 210 216 210 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1131 1136 1131 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1</italic>
###xml 1198 1204 1198 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 1265 1271 1265 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 104 107 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 112 118 <span type="species:ncbi:9606">humans</span>
###xml 242 245 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 468 471 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 643 646 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 1221 1224 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
It should be noted that several defensin genes on 8p23.1, but not DEFB1, exhibit copy number variation (CNV) in humans [41]; a more recent [42] genome-wide analysis of CNVs indicated that the 5' gene region of DEFB1 might be encompassed by a CNV, although the authors indicate that, since the breakpoints are difficult to establish, involved loci might flank rather than be encompassed by the CNVs. The authors studied HapMap subjects and reported a frequency for the CNV ranging from 6% to 14% in different populations. Since our YRI samples comprise a subset of HapMap YRI subjects, we checked whether any of them were reported to display a CNV in this region: two subject were retrieved, accounting for one gain and one loss. Electropherograms of these two subjects (as well as all other subjects in this study) revealed no evidence of unbalanced peaks at heterozygous SNPs and their removal from the sample did not affect the results for YRI. Previous [43] work had studied CNVs in the defensin cluster on chromosome 8 using real-time PCR assays and found that 24 American subjects with different ethnic origin had 2 copies of DEFB1. Taking these observations together, we consider that either DEFB1 lies outside the CNV or, in any case, that CNVs encompassing DEFB1 are very rare and do not affect the results reported here.
###end p 29
###begin title 30
Haplotype analysis
###end title 30
###begin p 31
###xml 185 191 185 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 284 285 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 813 814 811 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 907 917 <span type="species:ncbi:9598">chimpanzee</span>
###xml 922 928 <span type="species:ncbi:9606">humans</span>
One effect of balancing selection is to preserve two or more lineages over an extended period of time, resulting in clades separated by long branch lengths. To examine the genealogy of DEFB1 promoter haplotypes, we built a median-joining network. The topology of this network (Figure 2) is unambiguous with no reticulations, a pattern consistent with the low level of recombination observed in this gene region (not shown). Two major clades (haplogroups 1 and 2) separated by long branch lengths are evident, each containing one common haplotype. We next wished to estimate the time to the most recent common ancestor (TMRCA) of the two haplotype clades, applying a phylogeny-based method [44] based on the measure rho, the average distance of descendant haplotypes from a specified root. By using root 1 (Figure 2), rho was equal to 9.45 so that, with a mutation rate based on 21 fixed differences between chimpanzee and humans and a separation time of 5 million years ago, we estimated a TMRCA of 4,489,791 years (standard deviation +/-1,018,128).
###end p 31
###begin p 32
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 448 457 <span type="species:ncbi:9600">orangutan</span>
Genealogy of DEFB1 haplotypes reconstructed through a median-joining network. Each node represents a different haplotype, with the size of the circle proportional to the haplotype frequency. Also, circles are color-coded according to population (green, AA; black, YRI; blue, EA; yellow, AS; red, SAI; gray, AUA). The red arrow indicates root 1 (see text). Nucleotide differences between haplotypes are indicated on the branches of the network. The orangutan sequence is also shown.
###end p 32
###begin title 33
Comparison with other primates
###end title 33
###begin p 34
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 238 244 238 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pongo </italic>
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 495 500 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 524 529 524 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trans</italic>
###xml 710 712 710 712 <sub xmlns:xlink="http://www.w3.org/1999/xlink">e </sub>
###xml 732 734 732 734 <sub xmlns:xlink="http://www.w3.org/1999/xlink">e </sub>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 977 979 977 979 <sub xmlns:xlink="http://www.w3.org/1999/xlink">e </sub>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1014 1016 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1069 1074 1069 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1246 1250 1246 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pan </italic>
###xml 125 136 <span type="species:ncbi:9598">chimpanzees</span>
###xml 145 154 <span type="species:ncbi:9600">orangutan</span>
###xml 385 396 <span type="species:ncbi:9598">chimpanzees</span>
###xml 427 432 <span type="species:ncbi:9606">human</span>
###xml 459 465 <span type="species:ncbi:9606">humans</span>
###xml 802 808 <span type="species:ncbi:9606">humans</span>
###xml 890 896 <span type="species:ncbi:9606">humans</span>
###xml 901 912 <span type="species:ncbi:9598">chimpanzees</span>
###xml 1052 1057 <span type="species:ncbi:9606">human</span>
###xml 1058 1068 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1236 1241 <span type="species:ncbi:9606">human</span>
In order to gain further insight into the evolutionary history of the DEFB1 promoter region, we resequenced those from three chimpanzees and one orangutan. These samples were obtained from the European Collection of Cell Cultures and the Pongo sequence was used in the median-joining network in order to root the phylogeny (Figure 2). A total of 5 polymorphic sites were identified in chimpanzees; one of them (-913 C/T in the human sequence) was shared with humans and, therefore, represents a trans-specific polymorphism. Trans-specific polymorphisms are an effect of long-term balancing selection, while they are highly unlikely under neutrality. Indeed, a neutral polymorphism is expected to persist for 4Ne generations (where Ne is the effective population size, estimated to be around 10,000 for humans) [45] and, therefore, the probability of observing a polymorphism shared between humans and chimpanzees, two species that diverged about 5 million years ago (around 20Ne generations), is extremely low [46,47]. Although the identification of a human/chimpanzee trans-specific SNP is consistent with the estimated TMRCA of the haplotype clusters (suggesting that balancing selection was established around the same time when the human and Pan lineages split), the possibility exists that the shared SNP is due to a coincidental mutation that occurred after speciation. Indeed, the location of the substitution at a CpG site makes the possibility of a recurrent mutation more likely and, therefore, taking into account the lack of functional data on this SNP, it is difficult to discriminate between the two possibilities.
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 22 24 22 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 512 513 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 943 944 943 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 945 946 945 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 968 969 968 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 108 113 <span type="species:ncbi:9606">human</span>
###xml 193 198 <span type="species:ncbi:9606">human</span>
###xml 233 238 <span type="species:ncbi:9606">human</span>
Haldane's hypothesis [48] as formulated in 1932 posits that infectious diseases have been a major threat to human populations and have, therefore, exerted strong selective pressures throughout human history. As a result, a number of human loci are thought to have evolved in response to such pressures. Up to now, most evolutionary studies have focused on adaptive immunity, yet the ancient innate immune system, with the production of antimicrobial peptides, provides a critical line of defense in vertebrates [5]. Following Haldane's idea, it is conceivable, therefore, that innate immunity genes have undergone similar selective pressures as their adaptive counterparts. Indeed, in analogy to immunoglobulins [49] and major histocompatibility complex (MHC) molecules [50], the paradigm whereby gene duplication followed by rapid divergence has been a powerful adaptive strategy in immune response genes has been verified for defensin loci [6,7,51]. Recent studies [7] demonstrated that, after gene duplication in an ancestral mammalian genome, the mature peptide-coding exons of beta-defensins have been subjected to positive selection, while sites within the pre-propeptide region have undergone negative selection in primate lineages.
###end p 36
###begin p 37
###xml 179 184 179 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1</italic>
###xml 227 233 227 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 418 424 418 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 173 178 <span type="species:ncbi:9606">human</span>
###xml 545 550 <span type="species:ncbi:9606">human</span>
###xml 555 565 <span type="species:ncbi:9598">chimpanzee</span>
The data we report add further complexity to the evolutionary history of defensin genes by showing that balancing selection has shaped variability at the promoter region of human DEFB1. Indeed, we have documented here that the DEFB1 promoter region displays elevated nucleotide diversity, excess of polymorphism to divergence levels and reduced population differentiation. In line with these findings, the analysis of DEFB1 haplotypes revealed the presence of two clades separated by long branches approximately dating back to the time when the human and chimpanzee lineages split. Altogether, these features represent strong molecular signatures of long-term balancing selection, a process that is thought to be extremely rare outside MHC genes [47].
###end p 37
###begin p 38
###xml 156 172 150 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 174 196 168 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas aeruginosa</italic>
###xml 202 223 196 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae</italic>
###xml 247 255 241 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
###xml 264 266 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 267 269 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 430 432 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 433 435 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 556 579 544 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 594 596 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 709 711 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 720 726 708 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 760 762 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 763 765 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 1004 1010 992 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 1039 1041 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1071 1073 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 1229 1237 1214 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1238 1240 1223 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1413 1415 1398 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1416 1418 1401 1403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 156 172 <span type="species:ncbi:562">Escherichia coli</span>
###xml 174 196 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 202 223 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
###xml 479 484 <span type="species:ncbi:10090">mouse</span>
###xml 556 578 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 774 779 <span type="species:ncbi:9606">human</span>
###xml 1027 1032 <span type="species:ncbi:9606">human</span>
###xml 1100 1105 <span type="species:ncbi:9606">women</span>
###xml 1229 1236 <span type="species:ncbi:562">E. coli</span>
###xml 1341 1348 <span type="species:ncbi:9606">infants</span>
beta-Defensin 1, the first human beta-defensin to be discovered, shows anti-bacterial activity against a wide range of Gram-negative bacteria (for example, Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae), as well as different Candida species [52-54]. beta-defensin 1 is constitutively expressed by most epithelia with higher levels being detectable in kidney, pancreas, the urogenital and respiratory tracts [54-56]. Consistently, targeted disruption of the mouse beta-defensin 1 gene resulted in animals deficient in the clearance of Haemophilus influenzae from the lung [57] or containing a greater number of bacteria (Staphylococci, in particular) in urine collected from the bladder [58]. Also, DEFB1 expression has been demonstrated [59-61] in the human epidermis, gingival epithelium, oral mucosa and saliva, suggesting that it contributes to host defenses in areas exposed to a variety of microbial challenges. Moreover, recent evidences indicated that the protein product of DEFB1 is detectable in human milk [62] and the mammary epithelium [63]; in particular, pregnant women display higher levels of beta-defensin 1 and concentrations comparable to those observed in milk were effective in killing E. coli [62], suggesting that this antimicrobial peptide might have a fundamental role in protecting breast-fed infants from infectious diarrhea and mothers from lactational mastitis [62,63].
###end p 38
###begin p 39
###xml 23 29 23 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 620 634 620 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. aeruginosa </italic>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 720 728 720 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida </italic>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 848 850 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1059 1065 1059 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 1163 1165 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 1444 1451 1444 1451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CASP12 </italic>
###xml 1452 1454 1452 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 1516 1522 1516 1522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 1731 1733 1731 1733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1776 1790 1776 1790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. aeruginosa </italic>
###xml 1840 1842 1840 1842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1843 1845 1843 1845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1846 1848 1846 1848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 2101 2103 2101 2103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 2590 2592 2590 2592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 597 605 <span type="species:ncbi:9606">patients</span>
###xml 620 633 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 704 707 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 770 773 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 797 805 <span type="species:ncbi:9606">children</span>
###xml 1120 1127 <span type="species:ncbi:9606">infants</span>
###xml 1132 1140 <span type="species:ncbi:9606">children</span>
###xml 1339 1344 <span type="species:ncbi:9606">human</span>
###xml 1424 1429 <span type="species:ncbi:9606">human</span>
###xml 1768 1771 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1776 1789 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1829 1837 <span type="species:ncbi:9606">patients</span>
###xml 2300 2305 <span type="species:ncbi:9606">human</span>
The promoter region of DEFB1 has recently been subjected to extensive study; in particular, three SNPs have been reported to affect gene expression [17,64], although contrasting results on transcriptional activity have been obtained by different research groups, possibly reflecting either non-trivial interactions among polymorphic alleles at multiple positions or cell-type specific SNP effects [65]. In SNP typing studies, the -20A/-44C/-52G haplotype has been independently associated with protection against severe sepsis [13], susceptibility to asthma and atopy [12] and, in cystic fibrosis patients, with chronic P. aeruginosa lung infection [66]. Also, the -44C allele was shown to predispose to HIV [14,15] and Candida [16] infection, while an association with HIV infection in Brazilian children was also reported for SNPs -20G and -52A [15]. Although the biological bases for these associations are presently unknown, their description allows interesting speculations concerning the selective pressures possibly shaping nucleotide diversity at the DEFB1 promoter region. Sepsis is a leading cause of death in infants and children throughout the world [67]; its incidence and fatal outcome were conceivably higher before the advent of modern sanitation and, therefore, it might have represented a powerful selective force during human history. Indeed, signatures of natural selection have been reported at another human locus, namely CASP12 [68], as a possible adaptive response to sepsis. Variants in the DEFB1 promoter that protect against sepsis might, therefore, have conferred a selective advantage to carriers, although one or more of these same SNP alleles have been associated with predisposition to candidiasis [16], as well as to susceptibility to HIV and P. aeruginosa infection (at least in cystic fibrosis patients) [14,15,66]. In this respect, it is interesting to notice that early hunter-gatherer societies, due to their small population sizes, were likely to support a parasite fauna constituted of pathogens with high transmission rates and inducing little or no immunity [69]. In such a scenario, the role of innate response might have been extremely relevant to ensure protection from infectious agents. The increase in population size that occurred at some time during human history is thought to have allowed maintenance of a different and wider range of pathogen species, including major infectious agents responsible for sepsis. Variable environmental conditions are regarded as a possible explanation underlying the maintenance of balanced polymorphisms [70]; in a simplistic situation whereby a variant (or haplotype) protects against sepsis while predisposing to other infectious agents, changes in pathogen prevalence, with particular reference to microbes leading to fatal sepsis, might modulate the fitness of subjects carrying either allele.
###end p 39
###begin p 40
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 394 400 394 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 548 554 548 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 135 140 <span type="species:ncbi:9606">human</span>
###xml 254 259 <span type="species:ncbi:9606">human</span>
Unfortunately, little information is available concerning the early epidemiological history of our predecessors; indeed, the timing of human population expansion has been matter of debate [71-73] and some uncertainty concerns the time of origin of major human pathogens, for example, tuberculosis [74,75]. Further studies concerning these issues, as well as better understanding of the role of DEFB1 polymorphisms, will therefore be required before a direct link can be established between pathogen-driven selective pressure and the maintenance of DEFB1 variants.
###end p 40
###begin p 41
###xml 102 108 102 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 434 440 434 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 580 581 577 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 631 637 628 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 753 755 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 756 758 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 759 761 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 819 825 816 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 905 907 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1027 1029 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 1030 1032 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 1048 1054 1045 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
An additional, non-mutually exclusive possibility to explain the action of balancing selection at the DEFB1 promoter implies heterozygote advantage. This phenomenon is deemed responsible for maintenance of polymorphisms at MHC class II promoters [10,76] and is thought to enhance immune response flexibility by modulating allele-specific gene expression in different cell-types [77] and in response to diverse stimuli/cytokines [78]. DEFB1 is considered a constitutive defensin, in that, unlike beta-defensin 2, it shows limited inducibility by inflammatory stimuli (reviewed in [5]); however, previous reports have indicated that DEFB1 shows marked inter-individual variability in expression levels in urine, saliva, gingival epithelium and epidermis [56,59-61]. Similarly, the ability of lipopolysaccharide to induce DEFB1 expression varied among the blood samples obtained from 51 healthy individuals [53]. These data, together with the functional data indicating allele-dependent promoter activity in different cell types [64,65], suggest that DEFB1 variants might exert different effects in diverse tissues, possibly accounting both for inter-individual variation of expression levels and for maintenance of divergent clades.
###end p 41
###begin p 42
###xml 84 90 84 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 258 264 258 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 401 406 <span type="species:ncbi:9606">human</span>
It might also be worth mentioning that evidence, albeit preliminary, indicates that DEFB1 expression is up-regulated during pregnancy [56,62], suggesting hormone-regulated gene expression. No data have ever been reported concerning the response of different DEFB1 promoter haplotypes to hormone treatment; were any difference identified, the adaptive significance of variants increasing expression in human milk, for example, would be evident.
###end p 42
###begin p 43
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 325 331 325 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 565 571 565 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
Finally, it might be interesting to note that, given its high expression in urogenital tissues, DEFB1 has been regarded as a possible innate defense against sexually transmitted pathogens [56]. In line with this view, induction of an antiviral response in cultured uterine epithelial cells resulted in a six-fold increase in DEFB1 expression [79]. Since sexually transmitted diseases are thought to have affected early hominid societies, due to their sustainability in low-density host population [69], these observation might help to explain the ancient origin of DEFB1 haplotype clades.
###end p 43
###begin p 44
###xml 192 196 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCR5</italic>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 507 512 507 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCR5 </italic>
###xml 274 279 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 356 361 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 365 370 <span type="species:ncbi:9606">human</span>
###xml 657 662 <span type="species:ncbi:9606">human</span>
As discussed in the introduction, two recent reports indicated that balancing selection has shaped variability at the promoter region of other loci involved in immune response. In the case of CCR5, available evidence indicates that heterozygosity at this gene region delays HIV-1 disease progression [80]. However, as the authors note, the introduction of HIV-1 in human populations is relatively recent and cannot, therefore, account for the maintenance of balanced polymorphisms in the region; therefore, CCR5 possibly evolved to respond to older pathogens, providing a clue to the difficult task of inferring the origin of selective pressures exerted by human pathogens over long evolutionary times.
###end p 44
###begin p 45
###xml 107 113 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 296 302 296 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 535 541 535 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
Whatever the reason for the maintenance of a balanced variant, it is interesting to note that variation at DEFB1 might fit a previously proposed hypothesis [81] whereby alleles that conferred resistance to pathogens in ancient settings are now associated with susceptibility to atopic disorders; DEFB1 haplotypes associated with protection against sepsis seem to predispose to asthma and atopy. A similar link between past selection and present disease predisposition has been suggested [82] in the case of polymorphic variants in the IL4RA gene and might help to explain the high prevalence of atopic conditions in modern societies.
###end p 45
###begin title 46
Conclusion
###end title 46
###begin p 47
###xml 23 29 23 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 356 362 356 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 549 555 549 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
Association studies of DEFB1 variants have focused on a small number of SNPs to be genotyped; it is possible, therefore, that additional variants in this gene region play a role in the above described (or still unknown) conditions. In this regard, it is worth mentioning that the availability of full gene resequencing data allowed us to define a specific DEFB1 gene region as the target of balancing selection and, therefore, as the location of functional variants. This information might be valuable in future association studies, suggesting that DEFB1 promoter SNPs, rather than linked variants, associate with specific phenotypes.
###end p 47
###begin p 48
This report represents an example of how population genetics approaches may benefit from association studies by gaining cues about possible selective pressures acting on target gene regions; we hope it also illustrates the possible contribution of evolutionary models to classic SNP-disease association approaches by providing information about the localization of candidate functional variants.
###end p 48
###begin title 49
Materials and methods
###end title 49
###begin title 50
DNA samples and sequencing
###end title 50
###begin p 51
###xml 259 274 259 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pan troglodytes</italic>
###xml 295 309 295 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pongo pygmaeus</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 246 257 <span type="species:ncbi:9598">chimpanzees</span>
###xml 259 274 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 284 293 <span type="species:ncbi:9600">orangutan</span>
###xml 295 309 <span type="species:ncbi:9600">Pongo pygmaeus</span>
Human genomic DNA was obtained from the European Collection of Cell Cultures (Ethnic Diversity DNA Panel plus additional samples for Australian Aborigine derived from HLA defined panels). From the same source we obtained the genomic DNA of three chimpanzees (Pan troglodytes) and one orangutan (Pongo pygmaeus). Additional DNA samples from South American Indians and Yoruba individuals were derived from the Coriell Institute for Medical Research.
###end p 51
###begin p 52
###xml 50 56 50 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
The 1.4 kb region covering the promoter region of DEFB1 was PCR amplified (primer sequences are reported in Table 3). PCR products were treated with ExoSAP-IT (USB Corporation, Cleveland, OH, USA), directly sequenced on both strands with a Big Dye Terminator sequencing Kit (v3.1 Applied Biosystems, Monza, Italy) and run on an Applied Biosystems ABI 3130 XL Genetic Analyzer. All sequences were assembled using AutoAssembler version 1.4.0 (Applied Biosystems), inspected manually by two distinct operators, and singletons were re-amplified and resequenced.
###end p 52
###begin p 53
Primer sequences
###end p 53
###begin p 54
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 48 58 <span type="species:ncbi:9598">chimpanzee</span>
Primers used for amplification of human (H) and chimpanzee (C) templates.
###end p 54
###begin title 55
Data retrieval and haplotype construction
###end title 55
###begin p 56
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 414 419 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1</italic>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
DEFB1 genotype data for American subjects of either African or European descent were retrieved from the IIPGA website [19]. From the same source, we derived resequencing data referring to promoter regions (2 kb upstream of the translation initiation site) of other innate immunity genes genotyped for AA and EA. Promoter regions were not selected if the initial ATG was not located in the first exon (as it is for DEFB1) or if it could not be unequivocally identified due to the presence of multiple 5' isoforms, which were identified through manual inspection of UCSC annotation tracks [83]. Also, promoter regions were discarded if located in recombination hotspots (these were manually identified through the UCSC genome annotation tables snpRecombHotspotHapmap and snpRecombHotspotPerlegen [83]) or in resequencing gaps. A total of 20 promoter regions finally constituted the control dataset.
###end p 56
###begin p 57
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 34 39 <span type="species:ncbi:9606">human</span>
Genotype data for 231 resequenced human genes were derived from the NIEHS SNPs Program web site [35]. In particular, we selected genes that had been resequenced in populations of defined ethnicity, including Asians (NIEHS panel 2).
###end p 57
###begin p 58
###xml 50 52 50 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
Haplotypes were inferred using PHASE version 2.1 [20,21], a program for reconstructing haplotypes from unrelated genotype data through a Bayesian statistical method. Haplotypes for AS, AUA, SAI and YRI individuals are available as supporting information (Additional data file 1).
###end p 58
###begin title 59
Statistical analysis
###end title 59
###begin p 60
###xml 12 14 12 14 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 40 42 40 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 93 95 89 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink">W </sub>
###xml 96 98 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 108 110 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 134 146 129 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">libsequence </italic>
###xml 147 149 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B84">84</xref>
###xml 345 348 340 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ms </italic>
###xml 358 360 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B85">85</xref>
###xml 546 551 541 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cosi </italic>
###xml 560 562 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 656 659 651 654 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ST </sub>
###xml 670 672 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 767 772 762 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 775 777 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B86">86</xref>
###xml 878 880 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B87">87</xref>
Tajima's D [31], Fu and Li's D* and F* [32] statistics, as well as diversity parameters thetaW [22] and pi [23] were calculated using libsequence [84], a C++ class library providing an object-oriented framework for the analysis of molecular population genetic data. Departure from neutrality was tested from coalescent simulations computed with ms software [85] fixing the mutation parameter, assuming no intra-locus recombination and a constant population size with 100,000 iterations. Calibrated coalescent simulations were performed using the cosi package [37] and its best-fit parameters for YRI, AA, EA and AS populations with 10,000 iterations. The FST statistic [38] estimates genetic differentiation among populations and was calculated as proposed by Hudson et al. [86]. Significance was assessed by permuting 10,000 times the haplotype distribution among populations [87].
###end p 60
###begin p 61
###xml 40 51 40 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">libsequence</italic>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 198 213 198 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rhesus macaque </italic>
###xml 383 389 383 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 198 212 <span type="species:ncbi:9544">Rhesus macaque</span>
Pairwise HKA tests were performed using libsequence. The maximum-likelihood-ratio HKA test was performed using the MLHKA software [27] with multilocus data of 20 selected IIPGA promoter regions and Rhesus macaque (NCBI rheMac2) as an outgroup. In particular, we evaluated the likelihood of the model under two different assumptions: that all loci evolved neutrally and that only the DEFB1 promoter region was subjected to natural selection; statistical significance was assessed by a likelihood ratio test. We used a chain length (the number of cycles of the Markov chain) of 500,000 and, as suggested by the authors, we ran the program several times with different seeds to ensure stability of results.
###end p 61
###begin p 62
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 215 216 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B88">88</xref>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B89">89</xref>
###xml 414 415 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 432 438 432 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
In order to test for gene conversion events, we applied Sawyer's gene conversion algorithm [24] implemented in the GENECONV program. GENECONV assesses significance using two methods: permutations and an approximate p-value [88,89]. We performed several tests by varying the mismatch penalty from 0 to larger positive values and using 10,000 permutations. For all these runs and both methods, no pairwise or global p-value involving DEFB1 was significant, suggesting no inner or outer fragments showing past gene conversion.
###end p 62
###begin p 63
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 311 317 311 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 275 285 <span type="species:ncbi:9598">chimpanzee</span>
###xml 290 296 <span type="species:ncbi:9606">humans</span>
The median-joining network to infer haplotype genealogy was constructed using NETWORK 4.2 [44]. The time to the most common ancestor (TMRCA) was estimated using a phylogeny based approach implemented in NETWORK 4.2 using a mutation rate based on 21 fixed differences between chimpanzee and humans in the 1.4 kb DEFB1 region.
###end p 63
###begin p 64
###xml 54 56 54 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B90">90</xref>
All calculations were performed in the R environment [90].
###end p 64
###begin title 65
Abbreviations
###end title 65
###begin p 66
###xml 60 63 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
AA, African American; AS, Asian; AUA, Australian Aborigine; CNV, copy number variation; EA, European American; IIPGA, Innate Immunity PGA; MHC, major histocompatibility complex; SAI, South American Indian; SNP, single nucleotide polymorphism; TMRCA, time to the most recent common ancestor; YRI, Yorubans.
###end p 66
###begin title 67
Authors' contributions
###end title 67
###begin p 68
RC and SR performed all resequencing experiments and analyzed the data. MF and GM retrieved genotype data and performed population genetics analyses. MS, MF, RC, GPC and UP analyzed and interpreted the data. NB participated in the study coordination. MS and MF wrote the paper. MS conceived and coordinated the study.
###end p 68
###begin title 69
Additional data files
###end title 69
###begin p 70
###xml 66 67 66 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 99 105 99 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
The following additional data are available. Additional data file 1 is a spreadsheet reporting the DEFB1 promoter haplotypes for the following subjects: 22 YRI, 25 AS, 24 SAI and 12 AUA. SNP positions refer to the NCBI Build 36.1 assembly.
###end p 70
###begin title 71
Supplementary Material
###end title 71
###begin title 72
Additional data file 1
###end title 72
###begin p 73
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
DEFB1 promoter haplotypes are reported for AS, AUA, SAI and YRI.
###end p 73
###begin p 74
Click here for file
###end p 74
###begin title 75
Acknowledgements
###end title 75
###begin p 76
We are grateful to Roberto Giorda for helpful discussions about the manuscript.
###end p 76
###begin article-title 77
Gene-encoded peptide antibiotics and the concept of innate immunity: an update review.
###end article-title 77
###begin article-title 78
Defensins of vertebrate animals.
###end article-title 78
###begin article-title 79
Mammalian defensins in immunity: more than just microbicidal.
###end article-title 79
###begin article-title 80
Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense.
###end article-title 80
###begin article-title 81
Mammalian defensins in the antimicrobial immune response.
###end article-title 81
###begin article-title 82
Duplication and selection in the evolution of primate beta-defensin genes.
###end article-title 82
###begin article-title 83
The complexity of selection at the major primate beta-defensin locus.
###end article-title 83
###begin article-title 84
A strong signature of balancing selection in the 5' cis-regulatory region of CCR5.
###end article-title 84
###begin article-title 85
Evidence of balancing selection at the HLA-G promoter region.
###end article-title 85
###begin article-title 86
Ancient polymorphism and functional variation in the primate MHC-DQA1 5' cis-regulatory region.
###end article-title 86
###begin article-title 87
###xml 59 64 <span type="species:ncbi:9606">human</span>
An ancient balanced polymorphism in a regulatory region of human major histocompatibility complex is retained in Chinese minorities but lost worldwide.
###end article-title 87
###begin article-title 88
###xml 68 76 <span type="species:ncbi:9606">children</span>
Asthma and atopy are associated with DEFB1 polymorphisms in Chinese children.
###end article-title 88
###begin article-title 89
Genomic variations within DEFB1 are associated with the susceptibility to and the fatal outcome of severe sepsis in Chinese Han population.
###end article-title 89
###begin article-title 90
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 86 91 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 113 121 <span type="species:ncbi:9606">children</span>
A single-nucleotide polymorphism in the human beta-defensin 1 gene is associated with HIV-1 infection in Italian children.
###end article-title 90
###begin article-title 91
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 76 84 <span type="species:ncbi:9606">children</span>
DEFB1 gene polymorphisms and increased risk of HIV-1 infection in Brazilian children.
###end article-title 91
###begin article-title 92
###xml 42 47 <span type="species:ncbi:9606">human</span>
Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls.
###end article-title 92
###begin article-title 93
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma.
###end article-title 93
###begin article-title 94
The International HapMap Project.
###end article-title 94
###begin article-title 95
Innate Immunity in Heart, Lung and Blood Disease: Programs for Genomic Applications
###end article-title 95
###begin article-title 96
A new statistical method for haplotype reconstruction from population data.
###end article-title 96
###begin article-title 97
Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation.
###end article-title 97
###begin article-title 98
On the number of segregating sites in genetical models without recombination.
###end article-title 98
###begin article-title 99
Mathematical model for studying genetic variation in terms of restriction endonucleases.
###end article-title 99
###begin article-title 100
Statistical tests for detecting gene conversion.
###end article-title 100
###begin article-title 101
A test of neutral molecular evolution based on nucleotide data.
###end article-title 101
###begin article-title 102
The HKA test revisited: a maximum-likelihood-ratio test of the standard neutral model.
###end article-title 102
###begin article-title 103
The functional genomic distribution of protein divergence in two animal phyla: coevolution, genomic conflict, and constraint.
###end article-title 103
###begin article-title 104
Analysis of intronic conserved elements indicates that functional complexity might represent a major source of negative selection on non-coding sequences.
###end article-title 104
###begin article-title 105
The coalescent process in models with selection and recombination.
###end article-title 105
###begin article-title 106
Statistical method for testing the neutral mutation hypothesis by DNA polymorphism.
###end article-title 106
###begin article-title 107
Statistical tests of neutrality of mutations.
###end article-title 107
###begin article-title 108
###xml 44 49 <span type="species:ncbi:9606">human</span>
The matrix coalescent and an application to human single-nucleotide polymorphisms.
###end article-title 108
###begin article-title 109
###xml 45 50 <span type="species:ncbi:9606">human</span>
The allele frequency spectrum in genome-wide human variation data reveals signals of differential demographic history in three large world populations.
###end article-title 109
###begin article-title 110
National Institute of Environmental Health Sciences
###end article-title 110
###begin article-title 111
CYP3A variation and the evolution of salt-sensitivity variants.
###end article-title 111
###begin article-title 112
###xml 39 44 <span type="species:ncbi:9606">human</span>
Calibrating a coalescent simulation of human genome sequence variation.
###end article-title 112
###begin article-title 113
Genetical structure of populations.
###end article-title 113
###begin article-title 114
###xml 35 40 <span type="species:ncbi:9606">human</span>
Drift, admixture, and selection in human evolution: a study with DNA polymorphisms.
###end article-title 114
###begin article-title 115
Interrogating a high-density SNP map for signatures of natural selection.
###end article-title 115
###begin article-title 116
Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster.
###end article-title 116
###begin article-title 117
###xml 39 44 <span type="species:ncbi:9606">human</span>
Global variation in copy number in the human genome.
###end article-title 117
###begin article-title 118
Copy number polymorphisms are not a common feature of innate immune genes.
###end article-title 118
###begin article-title 119
Median-joining networks for inferring intraspecific phylogenies.
###end article-title 119
###begin article-title 120
###xml 22 27 <span type="species:ncbi:9606">human</span>
Allelic genealogy and human evolution.
###end article-title 120
###begin article-title 121
Neutral behavior of shared polymorphism.
###end article-title 121
###begin article-title 122
A limited role for balancing selection.
###end article-title 122
###begin article-title 123
Evolution of vertebrate immunoglobulin variable gene segments.
###end article-title 123
###begin article-title 124
Natural selection at major histocompatibility complex loci of vertebrates.
###end article-title 124
###begin article-title 125
Coordinated amino acid changes in the evolution of mammalian defensins.
###end article-title 125
###begin article-title 126
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis.
###end article-title 126
###begin article-title 127
###xml 56 61 <span type="species:ncbi:9606">human</span>
Differential expression of alpha- and beta-defensins in human peripheral blood.
###end article-title 127
###begin article-title 128
###xml 32 37 <span type="species:ncbi:9606">human</span>
Production of beta-defensins by human airway epithelia.
###end article-title 128
###begin article-title 129
###xml 48 53 <span type="species:ncbi:9606">human</span>
Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells.
###end article-title 129
###begin article-title 130
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.
###end article-title 130
###begin article-title 131
###xml 60 64 <span type="species:ncbi:10090">mice</span>
beta-Defensin 1 contributes to pulmonary innate immunity in mice.
###end article-title 131
###begin article-title 132
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Characterization of the mouse beta defensin 1, Defb1, mutant mouse model.
###end article-title 132
###begin article-title 133
###xml 37 42 <span type="species:ncbi:9606">human</span>
Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue.
###end article-title 133
###begin article-title 134
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 96 101 <span type="species:ncbi:9606">human</span>
Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin.
###end article-title 134
###begin article-title 135
Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands.
###end article-title 135
###begin article-title 136
###xml 9 14 <span type="species:ncbi:9606">human</span>
Abundant human beta-defensin-1 expression in milk and mammary gland epithelium.
###end article-title 136
###begin article-title 137
###xml 28 33 <span type="species:ncbi:9606">human</span>
Beta-defensin expression in human mammary gland epithelia.
###end article-title 137
###begin article-title 138
Transcriptional effect of DEFB1 gene 5' untranslated region polymorphisms.
###end article-title 138
###begin article-title 139
Transcriptional effect of DEFB1 gene 5' untranslated region polymorphisms.
###end article-title 139
###begin article-title 140
###xml 55 78 55 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas aeruginosa </italic>
###xml 55 77 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Association of beta-defensin-1 gene polymorphisms with Pseudomonas aeruginosa airway colonization in cystic fibrosis.
###end article-title 140
###begin article-title 141
Scope and epidemiology of pediatric sepsis.
###end article-title 141
###begin article-title 142
###xml 44 50 <span type="species:ncbi:9606">humans</span>
Spread of an inactive form of caspase-12 in humans is due to recent positive selection.
###end article-title 142
###begin article-title 143
###xml 0 6 <span type="species:ncbi:9606">People</span>
People and disease.
###end article-title 143
###begin article-title 144
Balancing selection and its effects on sequences in nearby genome regions.
###end article-title 144
###begin article-title 145
###xml 13 18 <span type="species:ncbi:9606">human</span>
When did the human population size start increasing?
###end article-title 145
###begin article-title 146
Population growth makes waves in the distribution of pairwise genetic differences.
###end article-title 146
###begin article-title 147
###xml 35 40 <span type="species:ncbi:9606">human</span>
Genetic evidence for a Paleolithic human population expansion in Africa.
###end article-title 147
###begin article-title 148
###xml 55 81 55 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 55 81 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis.
###end article-title 148
###begin article-title 149
###xml 19 39 19 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. prototuberculosis</italic>
A re-evaluation of M. prototuberculosis.
###end article-title 149
###begin article-title 150
The distribution of variation in regulatory gene segments, as present in MHC class II promoters.
###end article-title 150
###begin article-title 151
Allelic variation in transcription modulates MHC class II expression and function.
###end article-title 151
###begin article-title 152
Functional effects of a natural polymorphism in the transcriptional regulatory sequence of HLA-DQB1.
###end article-title 152
###begin article-title 153
###xml 23 28 <span type="species:ncbi:9606">human</span>
Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C).
###end article-title 153
###begin article-title 154
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes.
###end article-title 154
###begin article-title 155
A review of the genetic epidemiology of resistance to parasitic disease and atopic asthma: common variants for common phenotypes?
###end article-title 155
###begin article-title 156
A population genetics study of single nucleotide polymorphisms in the interleukin 4 receptor alpha (IL4RA) gene.
###end article-title 156
###begin article-title 157
UCSC Genome Browser
###end article-title 157
###begin article-title 158
Libsequence: a C++ class library for evolutionary genetic analysis.
###end article-title 158
###begin article-title 159
Generating samples under a Wright-Fisher neutral model of genetic variation.
###end article-title 159
###begin article-title 160
Estimation of levels of gene flow from DNA sequence data.
###end article-title 160
###begin article-title 161
A statistical test for detecting geographic subdivision.
###end article-title 161
###begin article-title 162
Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes.
###end article-title 162
###begin article-title 163
Applications and statistics for multiple high-scoring segments in molecular sequences.
###end article-title 163
###begin article-title 164
The R Project for Statistical Computing
###end article-title 164

